Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,281 | -4,607 | -45,155 | -42,333 | -41,820 |
| Depreciation Amortization | 40,867 | 20,829 | 119,436 | 97,386 | 45,060 |
| Income taxes - deferred | -4,310 | -3,296 | N/A | -32,786 | N/A |
| Accounts receivable | -23,112 | -23,251 | N/A | 18,809 | N/A |
| Accounts payable and accrued liabilities | -5,420 | 32,183 | N/A | -21,849 | N/A |
| Other Working Capital | -38,491 | -5,724 | 9,487 | 10,994 | -46,320 |
| Other Operating Activity | 29,131 | -9,031 | -25,931 | 5,785 | -1,710 |
| Operating Cash Flow | $-54 | $7,102 | $57,837 | $36,007 | $-44,790 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,181 | -1,437 | -6,895 | -7,126 | -13,930 |
| Net Acquisitions | N/A | N/A | -12,500 | N/A | -437,530 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -2,000 |
| Investing Cash Flow | $-2,181 | $-1,437 | $-19,395 | $-7,126 | $-453,460 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -195 | N/A | N/A | N/A | N/A |
| Debt Repayment | -3,173 | -2,074 | N/A | -13,868 | N/A |
| Other Financing Activity | -2 | -2 | -23,314 | -2,417 | 420,510 |
| Financing Cash Flow | $-3,370 | $-2,076 | $-23,314 | $-16,285 | $420,510 |
| Exchange Rate Effect | -730 | -138 | 57 | 524 | -310 |
| Beginning Cash Position | 34,743 | 34,743 | 19,559 | 19,559 | 97,610 |
| End Cash Position | 28,408 | 38,194 | 34,743 | 32,678 | 19,550 |
| Net Cash Flow | $-6,335 | $3,451 | $15,185 | $13,120 | $-78,050 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54 | 7,102 | 57,837 | 36,007 | -44,790 |
| Capital Expenditure | -2,181 | -1,437 | N/A | -7,126 | N/A |
| Free Cash Flow | -2,235 | 5,665 | 57,837 | 28,881 | -44,790 |